Brimer v. Life Insurance Co. of North America

462 F. App'x 804
Court of Appeals for the Tenth Circuit·Decided February 10, 2012·No. 11-5032·Unpublished·Cited by 9 cases

Opinions

ORDER AND JUDGMENT*

SCOTT M. MATHESON, JR., Circuit Judge.

Kimberly Brimer and her sons, Matthew and Christopher Brimer, claim that they [805] are entitled to benefits under a group accident policy insuring their husband and father, James Brimer. The district court concluded that Life Insurance Company of North America (“LINA”) properly denied the Brimers’ claim.

Exercising jurisdiction under 28 U.S.C. § 1291, we affirm.

I. BACKGROUND

A. Mr. Brimer’s Death 1

On March 26, 2006, Kimberly and Matthew Brimer returned home after a weekend trip and found James Brimer lying on the kitchen floor. He was unresponsive. Ms. Brimer called 911. When medical personnel arrived, they pronounced her husband dead.

A police officer at the scene observed dried “foam cap” on Mr. Brimer’s chin area and on his shirt. The officer also found a bottle of Soma (a muscle relaxant also known as carisoprodol) on the kitchen table. Thirty-three of the 100 capsules were missing from the bottle, which had been filled just two days earlier on March 24.2

Mr. Brimer’s physician, Dr. Christopher Klotz, reported to police that he had prescribed pain medication to Mr. Brimer. According to Dr. Klotz, Ms. Brimer usually administered the medication to her husband, but because she had been out of town, Mr. Brimer may have administered the medication himself and exceeded the recommended amount.

An autopsy was performed the next day. According to the medical examiner’s report, Mr. Brimer’s femoral blood tested positive for hydrocodone, codeine, cariso-prodol, and meprobamate. His heart blood tested positive for diazepam, nordia-zepam, and acetaminophen.

The medical examiner noted that Mr. Brimer had a history of hypertension and back pain. The report concluded that the cause of death was “acute combined drug toxicity.” Brimer I, 2010 WL 3607632, at *2. Mr. Brimer’s death certificate listed the same immediate cause of death — acute combined drug toxicity due to the ingestion of codeine, diazepam, carisoprodol, and hydrocodone. The medical examiner’s report concluded that the manner of death was “accident.” Id.

B. Administrative Proceedings

As an American Airlines employee, Mr. Brimer was insured under a group accident policy (the “Policy”) issued by LINA. Under the Policy, LINA agree[d] to pay benefits for loss from bodily injuries:

a. caused by an accident which happens while an insured is covered by this policy; and
b. which, directly and from no other causes, result in a covered loss.

Aplt. Appx. at 1. LINA would not pay benefits if the loss fell within one of the Policy’s seven enumerated exclusions. In relevant part, the Policy’s exclusions provide the following:

No benefits will be paid for loss resulting from:
[806]*8061. [Intentionally self-inflicted injuries, or any attempt thereat.
6. Benefits will not be paid for loss covered by or resulting from sickness, disease, bodily infirmity or medical or surgical treatment thereof....
7. Voluntary self-administration of any drug or chemical substance not prescribed by, and taken according to the directions of, a licensed physician. (Accidental ingestion of a poisonous substance [is] not excluded.)

Id.

Ms. Brimer and her sons, Matthew and Christopher, are beneficiaries under the Policy and submitted a claim for benefits on or about November 14, 2006. LINA began collecting information relevant to the Brimers’ claim, including a toxicological opinion. The toxicologist opined “within a reasonable degree of scientific certainty” that “Mr. Brimer had not taken carisoprodol according to his prescribed dosage” and that the “concentrations of codeine, carisoprodol, and meprobamate found in Mr. Brimer’s post-mortem blood are greater than what would be expected with therapeutic doses.” Brimer II, 2011 WL 650329, at *2. LINA denied the Brim-ers’ claim under Exclusion 7 of the Policy.

The Brimers began an administrative appeal of LINA’s decision. They argued that Exclusion 7 applies to the voluntary self-administration of non-prescription drugs and that “Mr. Brimer ingested medication for which he had a valid prescription.” Aplt. Appx. at 6. On June 15, 2007, LINA informed the Brimers that it needed more time to evaluate the appeal and to determine whether the loss was covered under the Policy. It requested that the Brimers submit additional information, including “any information which [they felt supported] the fact that ... Mr. Brimer’s death was not the result of medical or surgical treatment or the result of a sickness, disease or bodily infirmity.” Id. at 5. The Brimers did not submit additional information. LINA requested this information again on July 11, 2007.

On July 12, 2007, a day after its second request for further information, LINA affirmed its adverse benefit determination. It based its decision on four grounds: (1) Mr. Brimer’s death was not accidental, (2) Exclusion 1 applies, (3) Exclusion 6 applies, and (4) Exclusion 7 applies. LINA informed the Brimers that they had exhausted all administrative appeal levels.

On July 23, 2007, the Brimers brought an action in state court alleging breach of contract and breach of the covenant of good faith and fair dealing. LINA removed the action to federal district court based on diversity jurisdiction and because the Brimers’ claim involved a plan governed by the Employee Retirement Income Security Act (“ERISA”) and thus presented a federal question.

C. District Court Proceedings

In the district court, the Brimers sought judicial review of LINA’s decision to deny benefits under the Policy. The district court issued two opinions, an initial and a revised opinion, affirming LINA’s denial of benefits.

In the initial opinion, Brimer I, the court rejected the Brimers’ argument that because LINA based the initial denial of their claim solely on Exclusion 7, “ ‘fundamental fairness’ require[d] LINA be held ... to Exclusion 7.” 2010 WL 3607632, at *4. The court concluded that the Brimers “had ample opportunity to supplement the Administrative Record prior to administrative appeal and to address the new grounds for exclusion in their briefs for this case.” Id. It also noted that “the remedy for LINA’s untimely notice of the additional grounds for denial is to allow [807] plaintiff to bring this suit and file additional evidence pertaining to the new grounds of denial. Plaintiffs have had that opportunity, and thus no further remedy is necessary.” Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Brimer v. Life Insurance Co. of North America, 462 F. App'x 804 (10th Cir. 2012).

462 F. App'x 804 (Brimer v. Life Insurance Co. of North America) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related